Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Posts 5 Percent Decline in Revenues for Fiscal Q3

NEW YORK (GenomeWeb News) - Accelrys today reported declining revenues for its fiscal third quarter, accompanied by a larger net loss and a double-digit decrease in general and administrative spending.
For the three months ended Dec. 31, 2007, revenue fell 5 percent to $19.6 million from $20.7 million in the comparable period of the prior year.
The company said in a statement that the decrease in revenue was due to a fall-off in orders for “de-emphasized products,” which was partially offset by growth in sales for its Pipeline Pilot “scientific operating platform.” Accelrys said that a one-time “service revenue benefit” of $300,000 in the third quarter of the prior fiscal year also contributed to the year-over-year revenue decline.
Mark Emkjer, president and CEO of Accelrys, said in a statement that orders for Pipeline Pilot “increased substantially” during the quarter, and that two undisclosed pharmaceutical companies ”significantly increased their investments” in the platform.
During a conference call today to discuss the third-quarter earnings, Accelrys CFO Rick Russo noted that the company recognizes its revenues ratably, and therefore expects the increase in orders in the third quarter to lead to an uptick in revenues for the company's fourth fiscal quarter, which ends March 31.  
Accelrys's quarterly net loss grew by 9 percent to $1.2 million, or $0.05 per share, from $1.1 million, or $0.04 per share, in the prior-year quarter.
Spending on product development fell by 4 percent to $4.5 million from $4.7 million, while sales and marketing expenses grew by nearly 8 percent to $9.6 million from $8.9 million.
Accelrys cut its general and administrative costs by 17 percent to $3.4 million from $4.1 million in the comparable quarter of 2007.
As of Dec. 31, Accelrys had cash, cash equivalents, restricted cash, and marketable securities of $65.8 million.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.